Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
GPs will support the group's expansion and focus on digitalisation
Fresh capital will be used to improve the platform's technology and expand the company's trader network
Exiting investors reap a 1.7x multiple and 20.5% IRR following the sale
EBRD and Global Finance exit the business after investing €23.5m in 2011